Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III KMW-1 in hospitalized patients with deep partial and full thickness thermal burns
jRCT2080224058Phase 3Completed
- Sponsor
- KAKEN PHARMACEUTICAL CO., LTD.
- Start
- Sep 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of anacaulase-bcdb in thermal injury, burn injury and full-thickness burn, sponsored by KAKEN PHARMACEUTICAL CO., LTD. Started Sep 2018; status: completed.
02
Drugs
anacaulase-bcdb
03
Conditions
thermal injuryburn injuryfull-thickness burn
Beyond the preview
Go deeper on jRCT2080224058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224058.